Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets
NCT01179646
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet
Sponsor
Kremers Urban Development Company